News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

  • Researchers link early prostate cancer to alterations in a program controlled by a "master regulator" of cell growth. This insight could open new avenues for preventing and treating prostate cancer.

Tags: BasicResearch, ProstateCancer

  • Disparities in outcomes for children with retinoblastoma — a rare eye tumor usually discovered in routine pediatric check-ups — suggest unequal access to primary care, researchers from Dana-Farber/Boston Children’s Cancer and Blood Disorders Center report in a study published in the journal JAMA Pediatrics. Although virtually all the children in the study survived, Hispanic children and children who lived in disadvantaged areas were more likely to lose an eye due to late diagnosis.

Tags: ChildhoodCancer, ChildhoodCancerSurvivorship, Disparities

  • Dana-Farber is petitioning a federal court to determine that one of its scientists, Gordon Freeman, PhD, and another researcher are co-inventors on a series of cancer immunotherapy patents previously issued to a Japanese researcher and Japanese drug company.

  • Drugs that inhibit CDK7 may be a new therapy for treating triple-negative breast cancer.

Tags: BreastCancer

  • A new drug for renal cell carcinoma slowed the growth of advanced kidney cancer in patients who became resistant to the first-line therapies that had previously kept it in check, according to results from a clinical trial led by Dana-Farber Cancer Institute.

Tags: TargetedTherapy

  • Dana-Farber scientists and colleagues use genome- and epigenome-editing tools to pinpoint disease-causing variants.

Tags: BasicResearch, Genomics

  • Almost one-third of families whose children were being treated for cancer faced food, housing or energy insecurity and one-quarter lost more than 40 percent of household income, according to a new study from Dana-Farber/Boston Children’s Cancer and Blood Disorders Center published in Pediatric Blood & Cancer.

Tags: ChildhoodCancer, CopingWithCancer

  • In the first ever randomized trial in the United States, researchers led by Dr. Wendy Chen will test whether aspirin helps women with breast cancer avoid recurrence and live longer.

Tags: BreastCancer

  • Dana-Farber Cancer Institute and Brigham and Women’s Hospital announced they have agreed to name Berkshire Medical Center Cancer Center as the first member of the new Dana-Farber/Brigham and Women’s Cancer Care Collaborative (DF/BWCCC).

Tags: Partnerships

  • Researchers from Dana-Farber/Boston Children's Cancer and Blood Disorders Center, using CRISPR-based gene editing techniques, have found that changes to a small stretch of DNA may circumvent the genetic defect behind sickle cell disease (SCD), according to a study published in the journal Nature.

Tags: Genomics, Genetics

Showing 1-10 of 628 items